Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/ZWINT_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/ZWINT_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Oral Cavity | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/OralCavity/ZWINT_pca_on_diff_genes.png) | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Skin | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Skin/ZWINT_pca_on_diff_genes.png) | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/ZWINT_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005178411 | Thyroid | ATC | negative regulation of nuclear division | 37/6293 | 56/18723 | 6.82e-07 | 9.30e-06 | 37 |
GO:00330464 | Thyroid | ATC | negative regulation of sister chromatid segregation | 30/6293 | 43/18723 | 1.36e-06 | 1.71e-05 | 30 |
GO:00330484 | Thyroid | ATC | negative regulation of mitotic sister chromatid segregation | 30/6293 | 43/18723 | 1.36e-06 | 1.71e-05 | 30 |
GO:20008164 | Thyroid | ATC | negative regulation of mitotic sister chromatid separation | 30/6293 | 43/18723 | 1.36e-06 | 1.71e-05 | 30 |
GO:00513044 | Thyroid | ATC | chromosome separation | 55/6293 | 96/18723 | 1.58e-06 | 1.93e-05 | 55 |
GO:000709312 | Thyroid | ATC | mitotic cell cycle checkpoint | 69/6293 | 129/18723 | 2.52e-06 | 2.96e-05 | 69 |
GO:00070944 | Thyroid | ATC | mitotic spindle assembly checkpoint | 27/6293 | 38/18723 | 2.64e-06 | 3.06e-05 | 27 |
GO:00711734 | Thyroid | ATC | spindle assembly checkpoint | 27/6293 | 38/18723 | 2.64e-06 | 3.06e-05 | 27 |
GO:00711744 | Thyroid | ATC | mitotic spindle checkpoint | 27/6293 | 38/18723 | 2.64e-06 | 3.06e-05 | 27 |
GO:19021004 | Thyroid | ATC | negative regulation of metaphase/anaphase transition of cell cycle | 29/6293 | 42/18723 | 2.85e-06 | 3.27e-05 | 29 |
GO:00315774 | Thyroid | ATC | spindle checkpoint | 27/6293 | 39/18723 | 5.83e-06 | 6.16e-05 | 27 |
GO:00519854 | Thyroid | ATC | negative regulation of chromosome segregation | 30/6293 | 45/18723 | 5.89e-06 | 6.18e-05 | 30 |
GO:19058194 | Thyroid | ATC | negative regulation of chromosome separation | 30/6293 | 45/18723 | 5.89e-06 | 6.18e-05 | 30 |
GO:000007513 | Thyroid | ATC | cell cycle checkpoint | 84/6293 | 169/18723 | 1.05e-05 | 1.04e-04 | 84 |
GO:001094813 | Thyroid | ATC | negative regulation of cell cycle process | 134/6293 | 294/18723 | 1.19e-05 | 1.15e-04 | 134 |
GO:190198813 | Thyroid | ATC | negative regulation of cell cycle phase transition | 116/6293 | 249/18723 | 1.33e-05 | 1.27e-04 | 116 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZWINT | SNV | Missense_Mutation | | c.452N>A | p.Ala151Glu | p.A151E | O95229 | protein_coding | tolerated(0.32) | benign(0.003) | TCGA-A8-A094-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZWINT | SNV | Missense_Mutation | novel | c.773A>G | p.Asp258Gly | p.D258G | O95229 | protein_coding | deleterious_low_confidence(0.01) | benign(0.217) | TCGA-B6-A0RE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZWINT | SNV | Missense_Mutation | rs758501648 | c.52N>A | p.Glu18Lys | p.E18K | O95229 | protein_coding | tolerated(0.29) | benign(0.006) | TCGA-BH-A0HP-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | doxorubicin | SD |
ZWINT | SNV | Missense_Mutation | | c.556N>C | p.Asp186His | p.D186H | O95229 | protein_coding | deleterious(0) | possibly_damaging(0.471) | TCGA-E2-A1IN-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD |
ZWINT | SNV | Missense_Mutation | novel | c.266C>A | p.Ala89Glu | p.A89E | O95229 | protein_coding | deleterious(0.01) | probably_damaging(0.944) | TCGA-E9-A295-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | SD |
ZWINT | insertion | Nonsense_Mutation | novel | c.326_327insTTGGTCTTTCTCCCTTGCTTATCTGTAGAAACAAATG | p.Ile110TrpfsTer9 | p.I110Wfs*9 | O95229 | protein_coding | | | TCGA-A7-A0CJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD |
ZWINT | insertion | Frame_Shift_Ins | novel | c.589_590insCTGGTTTACCTCTCTCTGCATCTGAGCTCTGCTC | p.Gln197ProfsTer37 | p.Q197Pfs*37 | O95229 | protein_coding | | | TCGA-A8-A07J-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR |
ZWINT | insertion | In_Frame_Ins | novel | c.697_698insTCA | p.Glu233delinsValLys | p.E233delinsVK | O95229 | protein_coding | | | TCGA-A8-A09D-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR |
ZWINT | insertion | Nonsense_Mutation | novel | c.696_697insCATTTGTCTTTATGATTTTCTAGTTGT | p.Ala232_Glu233insHisLeuSerLeuTerPheSerSerCys | p.A232_E233insHLSL*FSSC | O95229 | protein_coding | | | TCGA-A8-A09D-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR |
ZWINT | SNV | Missense_Mutation | | c.757N>A | p.Asp253Asn | p.D253N | O95229 | protein_coding | deleterious_low_confidence(0.02) | benign(0.066) | TCGA-FU-A5XV-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD |